ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global K Cells Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-8P7548
Home | Market Reports | Health| Nursing
Global K Cells Market Insights and Forecast to 2028
BUY CHAPTERS

Global K Cells Market Research Report 2025

Code: QYRE-Auto-8P7548
Report
September 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chipscreen Biosciences
Affimed NV
Altor Bioscience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest Inc
Bristol–Myers Squibb
NKT
Henry Ford Health Services

K Cells Market

The global market for K Cells was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Killer lymphocytes: referred to as K cells, are differentiated and developed from lymphoid stem cells in the bone marrow. They account for 5% to 7% of the total number of lymphocytes in the blood. They are smaller than T and B lymphocytes and are slightly larger in size. , are medium-sized lymphocytes with a diameter of about 9 to 12 μm. There are lysosomes and secretory granules in the cytoplasm. There are Fc receptors (antibody receptors) on the K cell membrane. When the antibody binds to the target cell (antigen), K cells use Fc receptors to bind to the Fc end of specific antibodies, causing the target cells to quickly lose activity and kill the target cells. K cells must be assisted by antibodies to have immune killing effects, so K cells are also called antibody-dependent Antibody dependent cell-mediated cytotoxic cell (ADCC), K cells mainly attack target cells that are larger than microorganisms, which can be virus-infected cells, such as liver cells in chronic active hepatitis. Due to the large size of these cells, It is difficult to be phagocytized. K cells have an extracellular killing effect. They can clear them and have a clear killing effect on tumor cells. The increase in K cells in the peripheral blood of allogeneic transplant patients shows that K cells are also involved in rejection reactions.
North American market for K Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for K Cells is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of K Cells include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for K Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding K Cells.
The K Cells market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global K Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the K Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of K Cells Market Report

Report Metric Details
Report Name K Cells Market
Segment by Type
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Segment by Application
  • Cancer
  • Cardiovascular Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of K Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of K Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the K Cells Market report?

Ans: The main players in the K Cells Market are Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services

What are the Application segmentation covered in the K Cells Market report?

Ans: The Applications covered in the K Cells Market report are Cancer, Cardiovascular Diseases, Others

What are the Type segmentation covered in the K Cells Market report?

Ans: The Types covered in the K Cells Market report are Mogamulizumab, Lorvotuzumab Mertansine, Others

1 K Cells Market Overview
1.1 Product Definition
1.2 K Cells by Type
1.2.1 Global K Cells Market Value Comparison by Type (2024 VS 2031)
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 K Cells by Application
1.3.1 Global K Cells Market Value by Application (2024 VS 2031)
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Global K Cells Market Size Estimates and Forecasts
1.4.1 Global K Cells Revenue 2020-2031
1.4.2 Global K Cells Sales 2020-2031
1.4.3 Global K Cells Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 K Cells Market Competition by Manufacturers
2.1 Global K Cells Sales Market Share by Manufacturers (2020-2025)
2.2 Global K Cells Revenue Market Share by Manufacturers (2020-2025)
2.3 Global K Cells Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of K Cells, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of K Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of K Cells, Product Type & Application
2.7 Global Key Manufacturers of K Cells, Date of Enter into This Industry
2.8 Global K Cells Market Competitive Situation and Trends
2.8.1 Global K Cells Market Concentration Rate
2.8.2 The Global 5 and 10 Largest K Cells Players Market Share by Revenue
2.8.3 Global K Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global K Cells Market Scenario by Region
3.1 Global K Cells Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global K Cells Sales by Region: 2020-2031
3.2.1 Global K Cells Sales by Region: 2020-2025
3.2.2 Global K Cells Sales by Region: 2026-2031
3.3 Global K Cells Revenue by Region: 2020-2031
3.3.1 Global K Cells Revenue by Region: 2020-2025
3.3.2 Global K Cells Revenue by Region: 2026-2031
3.4 North America K Cells Market Facts & Figures by Country
3.4.1 North America K Cells Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America K Cells Sales by Country (2020-2031)
3.4.3 North America K Cells Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe K Cells Market Facts & Figures by Country
3.5.1 Europe K Cells Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe K Cells Sales by Country (2020-2031)
3.5.3 Europe K Cells Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific K Cells Market Facts & Figures by Region
3.6.1 Asia Pacific K Cells Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific K Cells Sales by Region (2020-2031)
3.6.3 Asia Pacific K Cells Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America K Cells Market Facts & Figures by Country
3.7.1 Latin America K Cells Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America K Cells Sales by Country (2020-2031)
3.7.3 Latin America K Cells Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa K Cells Market Facts & Figures by Country
3.8.1 Middle East and Africa K Cells Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa K Cells Sales by Country (2020-2031)
3.8.3 Middle East and Africa K Cells Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global K Cells Sales by Type (2020-2031)
4.1.1 Global K Cells Sales by Type (2020-2025)
4.1.2 Global K Cells Sales by Type (2026-2031)
4.1.3 Global K Cells Sales Market Share by Type (2020-2031)
4.2 Global K Cells Revenue by Type (2020-2031)
4.2.1 Global K Cells Revenue by Type (2020-2025)
4.2.2 Global K Cells Revenue by Type (2026-2031)
4.2.3 Global K Cells Revenue Market Share by Type (2020-2031)
4.3 Global K Cells Price by Type (2020-2031)
5 Segment by Application
5.1 Global K Cells Sales by Application (2020-2031)
5.1.1 Global K Cells Sales by Application (2020-2025)
5.1.2 Global K Cells Sales by Application (2026-2031)
5.1.3 Global K Cells Sales Market Share by Application (2020-2031)
5.2 Global K Cells Revenue by Application (2020-2031)
5.2.1 Global K Cells Revenue by Application (2020-2025)
5.2.2 Global K Cells Revenue by Application (2026-2031)
5.2.3 Global K Cells Revenue Market Share by Application (2020-2031)
5.3 Global K Cells Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chipscreen Biosciences
6.1.1 Chipscreen Biosciences Company Information
6.1.2 Chipscreen Biosciences Description and Business Overview
6.1.3 Chipscreen Biosciences K Cells Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chipscreen Biosciences K Cells Product Portfolio
6.1.5 Chipscreen Biosciences Recent Developments/Updates
6.2 Affimed NV
6.2.1 Affimed NV Company Information
6.2.2 Affimed NV Description and Business Overview
6.2.3 Affimed NV K Cells Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Affimed NV K Cells Product Portfolio
6.2.5 Affimed NV Recent Developments/Updates
6.3 Altor BioScience
6.3.1 Altor BioScience Company Information
6.3.2 Altor BioScience Description and Business Overview
6.3.3 Altor BioScience K Cells Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Altor BioScience K Cells Product Portfolio
6.3.5 Altor BioScience Recent Developments/Updates
6.4 Innate Pharma
6.4.1 Innate Pharma Company Information
6.4.2 Innate Pharma Description and Business Overview
6.4.3 Innate Pharma K Cells Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Innate Pharma K Cells Product Portfolio
6.4.5 Innate Pharma Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda K Cells Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Takeda K Cells Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Sorrento Therapeutics
6.6.1 Sorrento Therapeutics Company Information
6.6.2 Sorrento Therapeutics Description and Business Overview
6.6.3 Sorrento Therapeutics K Cells Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sorrento Therapeutics K Cells Product Portfolio
6.6.5 Sorrento Therapeutics Recent Developments/Updates
6.7 NantKwest
6.7.1 NantKwest Company Information
6.7.2 NantKwest Description and Business Overview
6.7.3 NantKwest K Cells Sales, Revenue and Gross Margin (2020-2025)
6.7.4 NantKwest K Cells Product Portfolio
6.7.5 NantKwest Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb K Cells Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb K Cells Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 NKT
6.9.1 NKT Company Information
6.9.2 NKT Description and Business Overview
6.9.3 NKT K Cells Sales, Revenue and Gross Margin (2020-2025)
6.9.4 NKT K Cells Product Portfolio
6.9.5 NKT Recent Developments/Updates
6.10 Henry Ford Health Services
6.10.1 Henry Ford Health Services Company Information
6.10.2 Henry Ford Health Services Description and Business Overview
6.10.3 Henry Ford Health Services K Cells Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Henry Ford Health Services K Cells Product Portfolio
6.10.5 Henry Ford Health Services Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 K Cells Industry Chain Analysis
7.2 K Cells Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 K Cells Production Mode & Process Analysis
7.4 K Cells Sales and Marketing
7.4.1 K Cells Sales Channels
7.4.2 K Cells Distributors
7.5 K Cells Customer Analysis
8 K Cells Market Dynamics
8.1 K Cells Industry Trends
8.2 K Cells Market Drivers
8.3 K Cells Market Challenges
8.4 K Cells Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chipscreen Biosciences
Affimed NV
Altor Bioscience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest Inc
Bristol–Myers Squibb
NKT
Henry Ford Health Services
List of Tables
 Table 1. Global K Cells Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global K Cells Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global K Cells Market Competitive Situation by Manufacturers in 2024
 Table 4. Global K Cells Sales (g) of Key Manufacturers (2020-2025)
 Table 5. Global K Cells Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global K Cells Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global K Cells Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market K Cells Average Price (USD/g) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of K Cells, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of K Cells, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of K Cells, Product Type & Application
 Table 12. Global Key Manufacturers of K Cells, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global K Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in K Cells as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global K Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global K Cells Sales by Region (2020-2025) & (g)
 Table 18. Global K Cells Sales Market Share by Region (2020-2025)
 Table 19. Global K Cells Sales by Region (2026-2031) & (g)
 Table 20. Global K Cells Sales Market Share by Region (2026-2031)
 Table 21. Global K Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global K Cells Revenue Market Share by Region (2020-2025)
 Table 23. Global K Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global K Cells Revenue Market Share by Region (2026-2031)
 Table 25. North America K Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America K Cells Sales by Country (2020-2025) & (g)
 Table 27. North America K Cells Sales by Country (2026-2031) & (g)
 Table 28. North America K Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America K Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe K Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe K Cells Sales by Country (2020-2025) & (g)
 Table 32. Europe K Cells Sales by Country (2026-2031) & (g)
 Table 33. Europe K Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe K Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific K Cells Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific K Cells Sales by Region (2020-2025) & (g)
 Table 37. Asia Pacific K Cells Sales by Region (2026-2031) & (g)
 Table 38. Asia Pacific K Cells Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific K Cells Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America K Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America K Cells Sales by Country (2020-2025) & (g)
 Table 42. Latin America K Cells Sales by Country (2026-2031) & (g)
 Table 43. Latin America K Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America K Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa K Cells Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa K Cells Sales by Country (2020-2025) & (g)
 Table 47. Middle East and Africa K Cells Sales by Country (2026-2031) & (g)
 Table 48. Middle East and Africa K Cells Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa K Cells Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global K Cells Sales (g) by Type (2020-2025)
 Table 51. Global K Cells Sales (g) by Type (2026-2031)
 Table 52. Global K Cells Sales Market Share by Type (2020-2025)
 Table 53. Global K Cells Sales Market Share by Type (2026-2031)
 Table 54. Global K Cells Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global K Cells Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global K Cells Revenue Market Share by Type (2020-2025)
 Table 57. Global K Cells Revenue Market Share by Type (2026-2031)
 Table 58. Global K Cells Price (USD/g) by Type (2020-2025)
 Table 59. Global K Cells Price (USD/g) by Type (2026-2031)
 Table 60. Global K Cells Sales (g) by Application (2020-2025)
 Table 61. Global K Cells Sales (g) by Application (2026-2031)
 Table 62. Global K Cells Sales Market Share by Application (2020-2025)
 Table 63. Global K Cells Sales Market Share by Application (2026-2031)
 Table 64. Global K Cells Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global K Cells Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global K Cells Revenue Market Share by Application (2020-2025)
 Table 67. Global K Cells Revenue Market Share by Application (2026-2031)
 Table 68. Global K Cells Price (USD/g) by Application (2020-2025)
 Table 69. Global K Cells Price (USD/g) by Application (2026-2031)
 Table 70. Chipscreen Biosciences Company Information
 Table 71. Chipscreen Biosciences Description and Business Overview
 Table 72. Chipscreen Biosciences K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 73. Chipscreen Biosciences K Cells Product
 Table 74. Chipscreen Biosciences Recent Developments/Updates
 Table 75. Affimed NV Company Information
 Table 76. Affimed NV Description and Business Overview
 Table 77. Affimed NV K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 78. Affimed NV K Cells Product
 Table 79. Affimed NV Recent Developments/Updates
 Table 80. Altor BioScience Company Information
 Table 81. Altor BioScience Description and Business Overview
 Table 82. Altor BioScience K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 83. Altor BioScience K Cells Product
 Table 84. Altor BioScience Recent Developments/Updates
 Table 85. Innate Pharma Company Information
 Table 86. Innate Pharma Description and Business Overview
 Table 87. Innate Pharma K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 88. Innate Pharma K Cells Product
 Table 89. Innate Pharma Recent Developments/Updates
 Table 90. Takeda Company Information
 Table 91. Takeda Description and Business Overview
 Table 92. Takeda K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 93. Takeda K Cells Product
 Table 94. Takeda Recent Developments/Updates
 Table 95. Sorrento Therapeutics Company Information
 Table 96. Sorrento Therapeutics Description and Business Overview
 Table 97. Sorrento Therapeutics K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 98. Sorrento Therapeutics K Cells Product
 Table 99. Sorrento Therapeutics Recent Developments/Updates
 Table 100. NantKwest Company Information
 Table 101. NantKwest Description and Business Overview
 Table 102. NantKwest K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 103. NantKwest K Cells Product
 Table 104. NantKwest Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb K Cells Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. NKT Company Information
 Table 111. NKT Description and Business Overview
 Table 112. NKT K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 113. NKT K Cells Product
 Table 114. NKT Recent Developments/Updates
 Table 115. Henry Ford Health Services Company Information
 Table 116. Henry Ford Health Services Description and Business Overview
 Table 117. Henry Ford Health Services K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 118. Henry Ford Health Services K Cells Product
 Table 119. Henry Ford Health Services Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. K Cells Distributors List
 Table 123. K Cells Customers List
 Table 124. K Cells Market Trends
 Table 125. K Cells Market Drivers
 Table 126. K Cells Market Challenges
 Table 127. K Cells Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of K Cells
 Figure 2. Global K Cells Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global K Cells Market Share by Type: 2024 & 2031
 Figure 4. Mogamulizumab Product Picture
 Figure 5. Lorvotuzumab Mertansine Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global K Cells Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global K Cells Market Share by Application: 2024 & 2031
 Figure 9. Cancer
 Figure 10. Cardiovascular Diseases
 Figure 11. Others
 Figure 12. Global K Cells Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global K Cells Market Size (2020-2031) & (US$ Million)
 Figure 14. Global K Cells Sales (2020-2031) & (g)
 Figure 15. Global K Cells Average Price (USD/g) & (2020-2031)
 Figure 16. K Cells Report Years Considered
 Figure 17. K Cells Sales Share by Manufacturers in 2024
 Figure 18. Global K Cells Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest K Cells Players: Market Share by Revenue in K Cells in 2024
 Figure 20. K Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global K Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America K Cells Sales Market Share by Country (2020-2031)
 Figure 23. North America K Cells Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe K Cells Sales Market Share by Country (2020-2031)
 Figure 27. Europe K Cells Revenue Market Share by Country (2020-2031)
 Figure 28. Germany K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific K Cells Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific K Cells Revenue Market Share by Region (2020-2031)
 Figure 35. China K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America K Cells Sales Market Share by Country (2020-2031)
 Figure 46. Latin America K Cells Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa K Cells Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa K Cells Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E K Cells Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of K Cells by Type (2020-2031)
 Figure 56. Global Revenue Market Share of K Cells by Type (2020-2031)
 Figure 57. Global K Cells Price (USD/g) by Type (2020-2031)
 Figure 58. Global Sales Market Share of K Cells by Application (2020-2031)
 Figure 59. Global Revenue Market Share of K Cells by Application (2020-2031)
 Figure 60. Global K Cells Price (USD/g) by Application (2020-2031)
 Figure 61. K Cells Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global NK Cells Market Research Report 2024
Global Natural Killer Cell Therapeutics Market Research Report 2024
Global Immune Mediated Tumor Killing Assays Service Market Research Report 2025
Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NK Cell Isolation Kit Market Research Report 2025
Global NK Cell Expansion Kit Market Research Report 2025
Global Animal PBMC Isolation Kit Market Research Report 2024
Global Human NK Cell Isolation Kit Market Research Report 2024
Global Killer Cell Immunoglobulin Receptor KIR Assay Kit Market Research Report 2024
Global Cytotoxic T Cells CTL Market Research Report 2024
Global NK Cell Cytotoxicity Assay Service Market Research Report 2025
Global NK Cell Therapy Market Insights Forecast to 2030
Global The Human NK Cell Cytotoxicity Assay Kit Market Research Report 2025
Global Natural Killer Cells Therapeutics Market Insights Forecast to 2030
Global CD Antigen Cancer Therapy Market Research Report 2025
Global Tumor Immune Cell Therapy Market Research Report 2024
Global Natural Killer NK Cell Induction and Culture Kit Market Research Report 2025
Global Natural Killer Cell Therapy Market Insights Forecast to 2030
Global Peripheral Blood Lymphocyte Separation Medium Market Research Report 2024
Dendritic Cell Cancer Vaccine Immunotherapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions